我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
39
29 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
已完成
2
5.1%
尚未招募
29
74.4%
招募中
8
20.5%
暂无批准数据
- Goa government launches India's first state-level pricing policy to negotiate lower prices for expensive cancer and rare disease treatments with pharmaceutical companies. - The initiative targets therapies costing over Rs 50 lakh annually, starting with lung cancer treatments, and aims to extend access to more patients through confidential pricing agreements. - A specialized committee will oversee price negotiations and approvals, addressing Goa's growing healthcare burden of 1,500 new cancer cases annually with 5% yearly increase. - The policy framework focuses on proprietary drugs and equipment already procured by state medical institutions, setting a national precedent for equitable healthcare access.